Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children?

Christopher Breuer1, Charles Tuggle, Daniel Solomon

  • 1Department of Surgery, Division of Pediatric Surgery, Ohio State University College of Medicine, Columbus, OH, USA.

Insights

Pediatric thyroid surgery, while rare, involves various benign and malignant conditions. High-volume surgeons and multidisciplinary teams are crucial for managing these complex cases and improving outcomes in children.

Area of Science:

  • Pediatric Surgery
  • Endocrinology
  • Oncology

Background:

  • Thyroid diseases in children encompass benign conditions like Graves' disease and malignant types such as differentiated thyroid cancer (DTC) and medullary thyroid carcinoma (MTC).
  • While surgical guidelines exist, they often lack specific recommendations for pediatric thyroidectomy.
  • Pediatric thyroidectomy carries a higher risk of complications, including recurrent laryngeal nerve injury and hypoparathyroidism, compared to adult procedures.

Purpose of the Study:

  • To highlight the unique challenges and considerations in surgical management of pediatric thyroid diseases.
  • To emphasize the importance of specialized surgical expertise and multidisciplinary care for optimal outcomes in children.

Main Methods:

  • Review of current literature and practice guidelines regarding pediatric thyroid surgery.
  • Analysis of complication rates and risk factors associated with thyroidectomy in the pediatric population.

Main Results:

  • Thyroid cancer, particularly DTC and MTC, are the most common malignancies requiring surgery in children.
  • High-volume thyroid surgeons, often with experience extrapolated from adult cases, are essential due to the rarity of pediatric procedures.
  • Multidisciplinary collaboration is vital for comprehensive patient care.

Conclusions:

  • Pediatric thyroidectomy demands specialized surgical skills and a coordinated team approach involving various pediatric specialists.
  • Ensuring children undergo surgery with high-volume surgeons is critical to minimize complication risks and achieve the best possible clinical outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...